Covered recipient · General Payments record
JASWINDER SINGH RATTAN
Allopathic & Osteopathic Physicians Internal Medicine Nephrology
General Payments · PY2018–2024
$1,335.28
- Reported across 56 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $222.31 | 10 |
| Education | $44.58 | 3 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $105.26 | 4 |
| Takeda Pharmaceuticals U.S.A., Inc. | $64.39 | 3 |
| AKEBIA THERAPEUTICS INC | $24.61 | 1 |
| Recor Medical Inc | $22.31 | 1 |
| Retrophin, Inc. | $19.97 | 2 |
| GlaxoSmithKline, LLC. | $16.32 | 1 |
| Eurofins Viracor, Inc. | $14.03 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (13)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AKEBIA THERAPEUTICS INC | $24.61 | 09/11/2024 | Education | Undisputed | 01/23/2026 | 1145833283 | CMS |
| Amgen Inc. | $29.49 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111685024 | CMS |
| Amgen Inc. | $23.47 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111685026 | CMS |
| Amgen Inc. | $23.67 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117361290 | CMS |
| Amgen Inc. | $28.63 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117361292 | CMS |
| Eurofins Viracor, LLC | $14.03 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146417158 | CMS |
| GlaxoSmithKline, LLC. | $16.32 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116623601 | CMS |
| Recor Medical Inc | $22.31 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127686542 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $25.52 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137659883 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $20.39 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137659885 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $18.48 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137659887 | CMS |
| Travere Therapeutics, Inc. | $3.08 | 04/29/2024 | Education | Undisputed | 01/23/2026 | 1149950463 | CMS |
| Travere Therapeutics, Inc. | $16.89 | 04/29/2024 | Education | Undisputed | 01/23/2026 | 1149950467 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.